Hosted on MSN3h
UK research team to initiate study into Digostics at-home diabetes test
Oxford Biomedical Research Centre is set to initiate a study into a new at-home test for diagnosing type 1 diabetes (T1D) in ...
Guidelines needed for interpreting continuous glucose monitoring reports in those without diabetes, say researchers
With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...
Hundreds more physicians needed to address RI primary care shortage, experts say
CHARLESTOWN, R.I. (WPRI) — David Carlbert starts every morning by testing his blood sugar and taking his blood pressure. The 68-year-old has diabetes and other chronic pain issues, but has been ...
Paying attention to four health factors can help prevent new heart syndrome
About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...
The Conway Daily Sun6h
Provider receives advanced diabetes management certification
BERLIN — Coos County Family Health nurse practitioner Heather Beaudry has recently become a board-certified practitioner in ...
Australian women will soon be eligible for a menopause health check. Here’s what to expect
What is a menopause health assessment? And how will it improve the health care women receive during this stage in their lives ...
Rolling Out8h
Diabetes drugs show promise in reducing COPD complications
Research reveals GLP-1 and SGLT-2 medications may lower COPD exacerbation risk in diabetes, offering new hope for dual ...
Science Daily8h
A diabetes, heart failure, and kidney disease medication is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Cure Today9h
An Expert Breaks Down the Effect of Diabetes on Urothelial Cancer Treatment
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma ...
Cochrane12h
Does treatment with GLP-1 receptor agonists prevent complications for people with chronic kidney disease and diabetes?
• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...
Healio12h
Few hospitalized adults with type 2 diabetes prescribed SGLT2, GLP-1 medication
Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...